Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial
- 28 November 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 42 (3)
Abstract
To examine the effects of cognitive behavioral treatments for insomnia (CBT-I) and pain (CBT-P) in patients with comorbid fibromyalgia and insomnia. 113 patients (Mage=53, SD=10.9) were randomized to eight sessions of CBT-I (n=39), CBT-P (n=37), or a waitlist control (WLC, n=37). Primary [self-reported sleep onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE), sleep quality (SQ), pain ratings)] and secondary outcomes [dysfunctional attitudes about sleep (DBAS); actigraphy and polysomnography SOL, WASO, and SE; McGill Pain Questionnaire; Pain Disability Index; depression; anxiety] were examined at post-treatment and 6-months. Mixed effects analyses revealed both treatments improved self-reported WASO, SE, and SQ relative to control at post-treatment and follow-up, with generally larger effect sizes for CBT-I. DBAS improved in CBT-I only. Pain and mood improvements did not differ by group. Clinical significance analyses revealed the proportion of participants no longer reporting difficulties initiating and maintaining sleep was higher for CBT-I post-treatment and for both treatments at 6-months relative to control. Few participants achieved >50% pain reductions. Proportion achieving pain reductions >30% (~1/3) was higher for both treatments post-treatment and for CBT-I at 6-months relative to control. CBT-I and CBT-P improved self-reported insomnia symptoms. CBT-I prompted improvements of larger magnitude that were maintained. Neither treatment improved pain or mood. However, both prompted clinically meaningful, immediate pain reductions in one third of patients. Improvements persisted for CBT-I, suggesting CBT-I may provide better long-term pain reduction than CBT-P. Research identifying which patients benefit and mechanisms driving intervention effects is needed.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR055160)
This publication has 49 references indexed in Scilit:
- Nightly Analyses of Subjective and Objective (Actigraphy) Measures of Sleep in Fibromyalgia SyndromeThe Clinical Journal of Pain, 2011
- Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: A pilot, randomized controlled trialJournal of Health Psychology, 2011
- Daily Variations in Objective Nighttime Sleep and Subjective Morning Pain in Older Adults with Insomnia: Evidence of Covariation over TimeJournal of the American Geriatrics Society, 2010
- Epidemiology, costs, and the economic burden of fibromyalgiaArthritis Research & Therapy, 2009
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Cognitive-behavioral treatment of insomnia secondary to chronic pain.Journal of Consulting and Clinical Psychology, 2000
- Cognitive–behavioral treatment of insomnia secondary to chronic pain.Journal of Consulting and Clinical Psychology, 2000
- Identifying effective psychological treatments for insomnia: A meta-analysis.Journal of Consulting and Clinical Psychology, 1995
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- Credibility of analogue therapy rationalesJournal of Behavior Therapy and Experimental Psychiatry, 1972